Evolution of medical management of chronic rhinosinusitis

Annals of Otology, Rhinology and Laryngology

Volumn 115, Issue 9 II, 2006, Pages 54-60

  Vining, Eugenia M ^a,b,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOSPITAL OF SAINT RAPHAEL   (United States)

^c Nose and Throat Medical and Surgical Group   (United States)

Author keywords

Antibiotics; Chronic rhinosinusitis; Corticosteroids; Macrolides

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; CHLORIDE ION; CORTICOSTEROID; GENTAMICIN; MACROLIDE; PLACEBO; TOBRAMYCIN; ANTIINFECTIVE AGENT; DECONGESTIVE AGENT;

ANTIBIOTIC THERAPY; BACTERIAL INFECTION; BRONCHIOLITIS; CATARACT; CHRONIC RHINITIS; CHRONIC SINUSITIS; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID INDUCED OSTEOPOROSIS; CORTICOSTEROID THERAPY; CYSTIC FIBROSIS; DIAGNOSTIC IMAGING; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG SAFETY; ENDOSCOPY; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MYCOSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; QT PROLONGATION; REVIEW; RISK BENEFIT ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME; VIRUS INFECTION; CHRONIC DISEASE; CLASSIFICATION; QUALITY OF LIFE; RHINITIS; SINUSITIS;

ADRENAL CORTEX HORMONES; ANTI-BACTERIAL AGENTS; CHRONIC DISEASE; ENDOSCOPY; HUMANS; NASAL DECONGESTANTS; QUALITY OF LIFE; RHINITIS; SINUSITIS; TREATMENT OUTCOME;

EID: 33748938325     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/00034894061150s909     Document Type: Review

References (43)

1. Benninger MS, Ferguson BJ, Hadley JA, et al. Adult chronic rhinosinusitis: definitions, diagnosis, epidemiology, and pathophysiology. Otolaryngol Head Neck Surg 2003;129(suppl 1).
2. Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinosinusitis: establishing definitions for clinical research and patient care. Otolaryngol Head Neck Surg 2004;131(suppl 1).
3. Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol 2004;114(suppl 1):155-212.
4. Cryer J, Schipor I, Perloff JR, Palmer JN. Evidence of bacterial biofilms in human chronic sinusitis. ORL J Otorhinolaryngol Relat Spec 2004;66:155-8.
5. Slavin RG, Spector SL, Bernstein IL, et al. The diagnosis and management of sinusitis: a practice parameter update. J Allergy Clin Immunol 2005:116(suppl 1):S13-S47.
6. Stevenson DD, Hankammer MA, Mathieson DA, Christiansen SC, Simon RA. Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: long-term outcomes. J Allergy Clin Immunol 1996;98:751-8.
7. Schleimer RP. Glucocorticoids: their mechanism of action and use in allergic diseases. In: Adkinson NF, Yunginger JW, Busse WW, Bochner BS, Holgate ST, Simons FE, eds. Middleton's allergy: principles and practice. St Louis, Mo: Mosby, 2003:912-4.
8. Benninger MS, Hadley JA, Osguthorpe JD, et al. Techniques of intranasal steroid use. Otolaryngol Head Neck Surg 2004;130:5-24.
9. Mygind N. Effects of corticosteroid therapy in non-allergic rhinosinusitis. Acta Otolaryngol (Stockh) 1996;116:164-6.
10. Kupferberg SB, Bent JP III, Kuhn FA. Prognosis for allergic fungal sinusitis. Otolaryngol Head Neck Surg 1997;117:35-41.
11. Marple BF, Mabry RL. Comprehensive management of allergic fungal sinusitis. Am J Rhinol 1998;12:263-8.
12. Sambrook PN. How to prevent steroid induced osteoporosis. Ann Rheum Dis 2005;64:176-8.
13. Nadel DM, Lanza DC, Kennedy DW. Endoscopically guided cultures in chronic sinusitis. Am J Rhinol 1998;12:233-41.
14. Brook I. Microbiology and management of sinusitis. J Otolaryngol 1996;25:249-56.
15. Vogan JC, Bolger WE, Keyes AS. Endoscopically guided sinonasal cultures: a direct comparison with maxillary sinus aspirate cultures. Otolaryngol Head Neck Surg 2000;122:370-3.
16. Tantilipikorn P, Fritz M, Tanabodee J, Lanza DC, Kennedy DW. A comparison of endoscopic culture techniques for chronic rhinosinusitis. Am J Rhinol 2002;16:255-60.
17. Anand V, Levine H, Friedman M, et al. Intravenous antibiotics for refractory rhinosinusitis in nonsurgical patients: preliminary findings of a prospective study. Am J Rhinol 2003;17:363-8.
18. Buchman CA, Yellon RF, Bluestone CD. Alternative to endoscopic sinus surgery in the management of pediatric chronic rhinosinusitis refractory to oral antimicrobial therapy. Otolaryngol Head Neck Surg 1999;120:219-24.
19. Gross ND, McInnes RJ, Hwang PH. Outpatient intravenous antibiotics for chronic rhinosinusitis. Laryngoscope 2002;112:1758-61.
20. Lieser JD, Derkay CS. Pediatric sinusitis: when do we operate? Curr Opin Otolaryngol Head Neck Surg 2005;13:60-6.
21. Tanner SB, Fowler KC. Intravenous antibiotics for chronic rhinosinusitis: are they effective? Curr Opin Otolaryngol Head Neck Surg 2004;12:3-8.
22. Vaughan WC, Carvalho G. Use of nebulized antibiotics for acute infections in chronic sinusitis. Otolaryngol Head Neck Surg 2002;127:558-68.
23. Scheinberg PA, Otsuji A. Nebulized antibiotics for the treatment of acute exacerbations of chronic rhinosinusitis. Ear Nose Throat J 2002;81:648-52.
24. Ponikau JU, Sherris DA, Kita H, Kern EB. Intranasal antifungal treatment in 51 patients with chronic rhinosinusitis. J Allergy Clin Immunol 2002;110:862-6.
25. Ponikau JU, Sherris DA, Weaver A, Kita H. Treatment of chronic rhinosinusitis with intranasal amphotericin B: a randomized, placebo-controlled, double-blind pilot trial. J Allergy Clin Immunol 2005;115:125-31.
26. Kennedy DW, Senior BA, Gannon FH, Montone KT, Hwang P, Lanza DC. Histology and histomorphometry of ethmoid bone in chronic rhinosinusitis. Laryngoscope 1998;108:502-7.
27. Tovi F, Benharroch D, Gatot A, Hertzanu Y. Osteoblastic osteitis of the maxillary sinus. Laryngoscope 1992;102:426-30.
28. Giacchi RJ, Lebowitz RA, Yee HT, Light JP, Jacobs JB. Histopathologic evaluation of the ethmoid bone in chronic sinusitis. Am J Rhinol 2001;15:193-7.
29. Wright ED, Frenkiel S. Infectious adult rhinosinusitis: etiology, diagnosis, and management principles. J Otolaryngol 2005;34(suppl 1):S7-S13.
30. Desrosiers MY, Salas-Prato M. Treatment of chronic rhinosinusitis refractory to other treatments with topical antibiotic therapy delivered by means of a large-particle nebulizer: results of a controlled trial. Otolaryngol Head Neck Surg 2001;125:265-9.
31. Kudoh S, Azuma A, Yamamoto M, Izumi T, Ando M. Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. Am J Respir Crit Care Med 1998;157:1829-32.
32. Saiman L, Marshall BC, Mayer-Hamblett N, et al. Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial. JAMA 2003;290:1749-56.
33. Tamaoki J, Kadota J, Takizawa H. Clinical implications of the immunomodulatory effects of macrolides. Am J Med 2004;117(suppl 9A):5S-11S.
34. Majima Y. Clinical implications of the immunomodulatory effects of macrolides on sinusitis. Am J Med 2004;117(suppl 9A):20S-25S.
35. Siddiqui J. Immunomodulatory effects of macrolides: implications for practicing clinicians. Am J Med 2004;117(suppl 9A):26S-29S.
36. Liu BA, Juurlink DN. Drugs and the QT interval - caveat doctor. N Engl J Med 2004;351:1053-6.
37. Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med 2004;350:1013-22.
38. Ragab SM, Lund VJ, Scadding G. Evaluation of the medical and surgical treatment of chronic rhinosinusitis: a prospective, randomised, controlled trial. Laryngoscope 2004;114:923-30.
39. Wong IW, Omari TI, Myers JC, et al. Nasopharyngeal pH monitoring in chronic sinusitis patients using a novel four channel probe. Laryngoscope 2004;114:1582-5.
40. Wang X, Kim J, McWilliams R, Cutting GR. Increased prevalence of chronic rhinosinusitis in carriers of a cystic fibrosis mutation. Arch Otolaryngol Head Neck Surg 2005;131:237-40.
41. Lukacs GL, Durie PR. Pharmacologic approaches to correcting the basic defect in cystic fibrosis. N Engl J Med 2003;349:1401-4.
42. Knowles MR, Paradiso AM, Boucher RC. In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis. Hum Gene Ther 1995;6:445-55.
43. Wilschanski M, Yahav Y, Yaacov Y, et al. Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations. N Engl J Med 2003;349:1433-41.